BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3611882)

  • 1. [Effect of post operative maintenance chemotherapy against ovarian cancer].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1115-20. PubMed ID: 3611882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental chemotherapy of ovarian cancers heterotransplanted in nude mice].
    Sawada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Aug; 37(8):1400-8. PubMed ID: 2995515
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of yolk sac tumor heterotransplanted to nude mice (author's transl)].
    Sawada M; Hayakawa K; Matsui Y; Nishiura H; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1596-602. PubMed ID: 7240825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
    Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
    Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
    Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
    Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.
    Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1980; 4(2):83-7. PubMed ID: 7389060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil.
    Nakanishi H; Abe A; Inada K; Tsukamoto T; Yasui K; Tatematsu M
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):660-8. PubMed ID: 10592098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of leukoencephalopathy caused by HCFU].
    Kamata H; Murakami A; Miyagawa N; Yasui H; Nagano H; Abe S; Ueda K; Kisida S
    Gan No Rinsho; 1988 May; 34(6):783-6. PubMed ID: 3379758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1-hexylcarbamoyl-5-fluorouracil on spontaneous mammary adenocarcinoma of mice.
    Tokuzen R; Iigo M; Hoshi A; Kuretani K
    Gan; 1980 Oct; 71(5):724-8. PubMed ID: 7227721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer].
    Wada S; Yasumoto R; Kashihara N; Kishimoto T; Maekawa M; Hayahara N; Kawakita J; Nishijima T; Morikawa Y; Horii A
    Hinyokika Kiyo; 1992 Jan; 38(1):19-24. PubMed ID: 1546564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
    Tanaka T; Toujima S; Utsunomiya T; Yukawa K; Umesaki N
    Oncol Rep; 2008 Jul; 20(1):13-23. PubMed ID: 18575713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effects of high-dose cisplatin in hypertonic saline against human ovarian tumors heterotransplanted in nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Koizumi K; Okamoto E
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1103-7. PubMed ID: 3611881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
    Tsumura M; Yoshiga K; Takada K
    Cancer Res; 1988 Jul; 48(14):3977-80. PubMed ID: 3383192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
    Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
    Sawada M; Matsui Y; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2421-6. PubMed ID: 6663150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
    Sakurai K; Yoshiga K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the establishing individual protocol for effective chemotherapy of ovarian cancer--fundamental research using human tumor-nude mouse system].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1776-83. PubMed ID: 3429976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.